ThreoTech LLC settles patent infringement lawsuit on Magtein magnesium L-threonate
ThreoTech LLC has announced that it has reached a confidential settlement with Green Jeeva to end a patent infringement lawsuit regarding Magtein magnesium L-threonate.
Photo © iStockphoto.com/KLH49
ThreoTech LLC has announced that it has reached a confidential settlement with Green Jeeva to end a patent infringement lawsuit regarding Magtein magnesium L-threonate. The lawsuit was originally filed on August 15, 2024 in the Central District of California.
“Magtein is a unique dietary supplement ingredient protected by a variety of composition and use patents,” said Edward Lee, CEO of ThreoTech, LLC, in a press release. “Our patent portfolio and other intellectual property supporting Magtein magnesium L-threonate is strong. We stand ready to protect our intellectual property.”
ThreoTech LLC is the exclusive licensee of a portfolio of patents owned by Neurocentria Inc. Magtein has been shown in research to support sleep and cognitive health.
Brightseed launches clinically validated ingredient, Bio Gut Core, to support gut barrier function
May 21st 2025The low-dose, easy-to-formulate ingredient is a proprietary blend of two bioactives – N-trans caffeoyltyramine (NCT) and N-trans feruloyltyramine (NFT) – which were discovered by the company’s Forage AI platform.
A country-by-country blueprint for nutraceutical success in Europe
May 20th 2025The European nutraceutical market is growing rapidly, but the continent is not a monolith when it comes to consumer trends and product innovation. This article is a blue-print for what nutraceutical success looks like in different European countries.
